chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Vaccine vial was diluted with 1.8ml of diluent instead of 1.3ml. Pt was given 1 dose from that vial. Pt was monitored for 15 minutes after vaccine was administered and showed no signs or symptoms  of an adverse reaction. Patient was discharged home after the 15 minutes.
5 days after the first vaccine, I got shingles.  After the second vaccine, I got a skin infection.  After the first booster, I got thrush.  And the same day as the last booster on January 9, 2023 I had severe abdominal pain which landed me in the emergency room and in the hospital for 5 days with infectious colitis.
Shortness of breath; chest pain; body aches; joint pain; headache; nausea; congestion; This is a spontaneous report received from a non-contactable nurse (who is also the patient). A 26-year-old female patient received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: El0140), intramuscular in right arm, on 29Dec2020 17:30, at single dose, for COVID-19 immunization. Medical history included spontaneous pneumothorax x2 on the right with VATS surgery on an unspecified date and multiple food allergies. The patient is not pregnant. Concomitant medication included montelukast sodium (SINGULAIR) and loratadine (CLARITIN). The patient experienced shortness of breath, chest pain, body aches, joint pain, headache, nausea and congestion, all on 30Dec2020 at 05:00. The patient did not receive treatment for the events. The patent did not receive any other vaccines within 4 weeks prior to BNT162B2. Prior to vaccination, it was unknown if the patient was diagnosed with COVID-19. Since vaccination, the patient has not been tested for COVID-19. The outcome of the events was recovering. The reporter assessed the case as non-serious.  No follow-up attempts are possible. No further information is expected.
About 18 hours after receiving the vaccine I experienced flu-like symptoms:  aching muscles, chills, malaise, fever.  The symptoms lasted about 24 hours.
A spontaneous report  was received from a Consumer concerning a  patient of unspecified age who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events broke out in hives and rashes all over.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 1 Feb 2021, prior to the onset of the events the patient received their  dose of mRNA-1273 (lot/batch: unknown) through unknown route for prophylaxis of COVID-19 infection.    No treatment information was provided.  On an unspecified date, after dose of vaccine, the patient experienced  broke out in hives and rashes all over.   No treatment medication was reported.  Action taken with mRNA-1273 in response to the event was not applicable.  The outcome of the event,  broke out in hives and rashes all over was considered to be unknown  at the time of this report.
Right arm. Received shot at about 4PM. By 7PM pt states her pulse was not measurable. Developed a headache & fever. Received shot in deltoid and arm developed swelling down to mid-forearm that didn't go away for 3 or 4 days.
10/23/2003: Phone call 09:00, 48 hours after shots; about 5 inch area swollen and red, painful, warm to touch on right thigh.  Seen in office 10/23/2003 for shot reaction given Atarax.
pt had her  booster of covid vaccine she had 2 shots before  of pfizer from the past  and had lightheaded, now pt decided to haver her  booster of Moderna, 15 minutes after the vaccine pt started to have redness on her neck no tongue swelling no SOB, clear breath sounds. Pt took 4 tablets  of her own benadryl. Covid  vaccination manger notified. Observed pt for 1 hour , denies tingling, no tongue or lip swelling, no SOB, redness better. VS of 130/88, HR 97, O2 sat of 98% at RA RR 16 .
Red, raised bump, tender to the touch, still present more than 24 hours after immunization.
Very hot. Warm to touch; Large area of redness around his arm; Doubt if the shot was done intramuscularly; A spontaneous report was received from a nurse concerning a 55 year-old, male patient who received Moderna's COVID-19 vaccine and experienced a large area of redness around his arm, Very hot. Warm to the touch, and doubt if the shot was done intramuscularly.   The patient's medical history was not provided. Products known to have been used by the patient, within two weeks prior to the event, included regular medication for cholesterol, triglycerides and antidepressant.    On 27 Dec 2020, the patient received their first of two planned doses of mRNA-1273 in their left arm for prophylaxis of COVID-19 infection.   On 04 Jan 2021, the patient experienced a very large area of redness around his arm. Very hot. Warm to touch. The reporter noted that the person administering the vaccine did not have the right technique, and they doubt if the shot was done intramuscularly. Treatment information was not provided.   Action taken with mRNA-1273 in response to the events was unknown.  The events large area of redness around his arm and Very hot. Warm to the touch were considered not recovered/not resolved. The event doubt if the shot was done intramuscularly was considered recovered/resolved on 27 Dec 2020.; Reporter's Comments: This report refers to a case of product administration error for mRNA-1273 and concerns a 55 year-old, male patient, who experienced the events of injection site warmth and erythema. The event occurred 9 days after the first and only dose of mRNA-1273 vaccine administration. Based on the current limited available information and temporal association between the use of the product and the start of the events, a causal relationship cannot be excluded and the events are assessed as possibly related.
Chills and fever of about 100F lasting through the night. Next morning,  severe headache and extreme tiredness . Slight nausea and food unappetizing.  Extremely sore/weak legs (mostly right) developed mid day after fever/chills gone. After around 24 hrs most symptoms gone. Some remaining tiredness 36 hours afterwards as well as pain in neck and slight pain when breathing deeply (like caused by muscle strain) . No follow up with any physician as effects when away on own after 36-48 hours.
September 4, 2021, woke up to the most severe menstrual cramps I have ever experienced. My periods have been regular to the day (28 day cycle) since I began menstruating. I have never experienced even slight to moderate cramping. My periods have never lasted more than three or four days.  After my second dose of the Pfizer vaccine, I experienced two full days of severe menstrual cramping requiring the intake of Ibuprofen every few hours to endure the symptoms. (I do not take pharmaceutical meds unless no other alternative) Cramping did finally subside after the second day, but menstrual bleeding has continued through today- day 5 which has never happened before. While  this may not significant , I need to report it. After I discussed with a few friends they had said they had heard similar things and then somebody forwarded me an article stating this has been reported and being looked at. I wanted to make sure mine was recorded. I have an 11-year, 11 month -old daughter who just started menstruating. Once she turns 12 if she is mandated to get this vaccine I do not want her to get it until all of women's menstruation and reproductive possible complications are understood.
broke out in flat red rash on forehead, chest, surrounding ears & diaper area 4/19/99;T100.7 R;still drinking good;had positive test for strep throat @ Er;
got sick; Initial information  was received on 24-Nov-2022 regarding an unsolicited valid Social Media non-serious case received from a consumer/non-HCP.  This case involves a patient with unknown demographics who got sick after being vaccinated with Influenza vaccine.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect Influenza vaccine (produced by unknown manufacturer) (with unknown strength, dose, route, administration site, lot number and expiration date) for prophylactic vaccination.  On an unknown date the patient got sick (illness) (unknown latency) following the administration of Influenza vaccine.  Action taken: Not applicable.  Corrective treatment: Not reported.  Outcome: Unknown.
Arm is still hurting; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm is still hurting) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm is still hurting). At the time of the report, PAIN IN EXTREMITY (Arm is still hurting) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. No treatment information was provided.
Four minutes after receiving his vaccination, he had a brief episode of syncope. He was alert and oriented times four. He was taken to a brief session at the arena and monitored.
2nd dose pediaprofen 430PM from unresponsive to med, drowsy, refused fluids only slept in arms; pain pulling @ arms & legs; 930PM vomited-20 times, t101.5 ear; 11PM APAP given, 3AM vomited again, 530AM fussy started to improve;
The vial was initially stored in the refrigerator on 08-Jul-2022 and was administer on 09-Aug-2022.; No adverse event; Administered Moderna COVID-19 Vaccine after 30-day use by date.; This spontaneous case was reported by a physician assistant and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered Moderna COVID-19 Vaccine after 30-day use by date.), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 08-Jul-2022 and was administer on 09-Aug-2022.) and NO ADVERSE EVENT (No adverse event) in a 4-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AS1414B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 09-Aug-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 09-Aug-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered Moderna COVID-19 Vaccine after 30-day use by date.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 08-Jul-2022 and was administer on 09-Aug-2022.) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered Moderna COVID-19 Vaccine after 30-day use by date.), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 08-Jul-2022 and was administer on 09-Aug-2022.) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Administered Moderna COVID-19 Vaccine after 30-day use by date.) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 08-Jul-2022 and was administer on 09-Aug-2022.).    No concomitant product use was reported.  On 08-Jul-2022, the vials were initially stored in the refrigerator.  Vial did not undergo any temperature excursions.  The healthcare professional was not aware of any symptoms for any patient after the vaccine was given.  No treatment information was provided.
27 Aug 12 5:00 PM shot administered. 28 Aug 12 3:00 AM awoke with 104.7 fever, legs were paralyzed for a few minutes. 103 fever most of the day. 6:00 PM uncontrollable diarrhea, no notice, no pain. 29 Aug 12 Fever 101, diarrhea ended about 6:00 PM. 30 Aug 12 Better.
Swollen lymph nodes in subclavical area. One week past second dose and they are still enlarged.
Narrative: COVID infection following COVID vaccine series 02/22, Pfizer, dose #1 03/15, Pfizer, dose #2 08/03 pt cc: cough Rhinorrhea loss of taste or smell, fatigue, headache, myalgia, nausea, exposure: unknown 08/04 - 08/25 pt symptoms continue 08/16 COVID swab, result: detected 08/26 clinically resolved
mom reports pt cried inconsolably from 1PM until 930PM on the day of vax;also reports redness, swelling & inc warmth of the lt leg from the top of the thigh to below the knee;
Systemic: Abdominal Pain-Medium, Systemic: Dizziness / Lightheadness-Medium, Systemic: Flushed / Sweating-Medium, Systemic: Hypotension-Medium, Systemic: Tinnitus-Medium, Additional Details: Patient said he immediately felt pain in his lower abdomen on each side after receiving the vaccine. He then began to feel dizzy and his ears were ringing. He began sweating and felt like he was going to pass out. BP was 92/77 and then went up to 104/83 after 2 minutes, which the patient said is closer to normal range for him. Sweating stopped and patient said he was feeling better. Patient left the store when feeling better.
Pt presented with swollen, firm upper arm with a red splotchy rash. Pt reported pain when moving arm.  Pt developed first day post shot followed by the rash on the second day. Dr recommended ice to the shot site and ibuprofen for the pain.
Information has been received from a 62 year old male physician with environmental allergies, asthma and atopic dermatitis who on 09-NOV-2008 was vaccinated subcutaneously with a 0.5 ml dose of MMR II (rHA, lot # 660208/0454X). On 09-NOV-2008 the patient was also vaccinated with RECOMBIVAX HB (manufacturer unspecified). Other concomitant therapy included montelukast sodium (MSD) and ADVAIR. On 24-NOV-2008 the patient experienced pain and swelling of both wrists, hands right ankle and left knee after receiving the MMR II. The patient also experienced carpal tunnel syndrome in both hands. Laboratory diagnostic tests included sedimentation rate, C-reactive protein (CRP) and rubella IGM titer and the results were all within normal limits. The patient sought medical attention via office visit. At time of reporting, the patient was recovering. Pain and swelling of both wrists, hands, right ankle and left knee and carpal tunnel syndrome in both hands were considered to be disabling. Additional information has been requested.
TOOK ONE DOSE OF UNREFRIGERATED VIVOTIF; This spontaneous case report (PVX2019-1934) was received from a pharmacist on 26-Jul-2019. It described a male consumer who "took one dose of unrefrigerated Vivotif" (PT: Product storage error). The consumer was receiving oral Vivotif (one dose every other day; lot number: 3003276 and expiry date: 28-May-2020) for typhoid fever prophylaxis.  Case report: The consumer took first dose of Vivotif on 26-Jul-2019, which was unrefrigerated since 21-Jun-2019.  Action taken with Vivotif was not applicable.  The clinical outcome of the reported event was unknown.  Company's Comment: The causality of the event "took one dose of unrefrigerated Vivotif" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took one dose of unrefrigerated Vivotif" was considered as not applicable.
Itchy (at injection site); red at injection site; Sore (at injection site); This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itchy (at injection site)), VACCINATION SITE ERYTHEMA (red at injection site) and VACCINATION SITE PAIN (Sore (at injection site)) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PRURITUS (Itchy (at injection site)), VACCINATION SITE ERYTHEMA (red at injection site) and VACCINATION SITE PAIN (Sore (at injection site)). At the time of the report, VACCINATION SITE PRURITUS (Itchy (at injection site)), VACCINATION SITE ERYTHEMA (red at injection site) and VACCINATION SITE PAIN (Sore (at injection site)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment information was not reported.
Nausea; Mild vomiting (threw up small amount in mouth twice while sleeping); gestational period: 34; This is a spontaneous report from a non-contactable consumer, the patient. An 28 year-old female patient (pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 30Aug2021 at 14:00 (Batch/Lot number: unknown) at the age of 28 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. The patient was 34 weeks pregnant at the event onset. The patient is expected to deliver a baby(s) on 11Oct2021. Concomitant medication(s) included: FISH OIL; VITAMIN D NOS; CALCIUM; MAGNESIUM. The following information was reported: NAUSEA (non-serious) with onset 31Aug2021 at 04:00, outcome "not recovered", described as "Nausea"; VOMITING (non-serious) with onset 31Aug2021 at 04:00, outcome "not recovered", described as "Mild vomiting (threw up small amount in mouth twice while sleeping)"; MATERNAL EXPOSURE DURING PREGNANCY (non-serious) with onset 30Aug2021 at 14:00, outcome "unknown", described as "gestational period: 34".Therapeutic measures were not taken as a result of nausea, vomiting.  Additional information: The patient did not have any relevant medical history. The patient had no known allergies. The patient expected delivery date was 11Oct2021. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included unspecified prenatal (MANUFACTURER UNKNOWN), fish oil (MANUFACTURER UNKNOWN), vitamin D (MANUFACTURER UNKNOWN), calcium (MANUFACTURER UNKNOWN) and magnesium (MANUFACTURER UNKNOWN), all taken from unknown dates. On 31Aug2021 at 04:00, the patient experienced nausea and mild vomiting (threw up small amount in mouth twice while sleeping). The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events nausea and mild vomiting were not resolved at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
states redness 1st noticed 27APR94 & redness evident 2-3 inches above & below inject site; whelp like in nature; no fever or soreness; area over inject site warm to touch;
Itchy raised bumps noticed on face starting at chin and nasolabial fold. Continued over next 24 hours to include cheeks and jawline -- more on left side than right. OTC hydrocortisone cream applied for itchiness.
This case was reported by a other health professional and described the occurrence of arm was sore in a 45-year-old female patient who received FLUARIX QUADRIVALENT (batch number 7LE2S, expiry date 30th June 2015). Previously administered products included influenza vaccine with an associated reaction of no adverse event. On 4th September 2014, the patient received FLUARIX QUADRIVALENT. On 4th September 2014, less than a day after receiving FLUARIX QUADRIVALENT, the patient experienced arm was sore (serious criteria disability), limited range of motion (serious criteria disability), waking up at night (serious criteria disability) and pain (serious criteria disability). On an unknown date, the outcome of the arm was sore, limited range of motion, waking up at night and pain were not recovered/not resolved. The reporter considered the arm was sore, limited range of motion, waking up at night and pain to be probably related to FLUARIX QUADRIVALENT. Additional information received: The reporter was a nursing student. She reported that her nursing class (a total of 30-35 students) received Flu vaccines at a local hospital about a month ago. About 5 of the students experienced adverse events. She reported that this patient received the vaccine and experienced pain, her arm was sore, is experiencing a limited range of motion, and wakes up at night from the pain. The reporter reported that this patient's events were worse.
migraine; injection site big red dot or rash; had a chill; swollen lymph nodes; pain in her left breast; pain in her neck on the left; she did not feel good; felt like she was getting sick; pain under her left arm/pain in her left leg; pain in her arm/pain in her left arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in her arm/pain in her left arm), BREAST PAIN (pain in her left breast), NECK PAIN (pain in her neck on the left), FEELING ABNORMAL (she did not feel good) and ILLNESS (felt like she was getting sick) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 04AF21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 07-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Sep-2021, the patient experienced PAIN IN EXTREMITY (pain in her arm/pain in her left arm). On 13-Sep-2021, the patient experienced BREAST PAIN (pain in her left breast), NECK PAIN (pain in her neck on the left), FEELING ABNORMAL (she did not feel good), ILLNESS (felt like she was getting sick), PAIN (pain under her left arm/pain in her left leg  ), CHILLS (had a chill) and LYMPHADENOPATHY (swollen lymph nodes). On 16-Sep-2021, the patient experienced VACCINATION SITE RASH (injection site big red dot or rash). On an unknown date, the patient experienced MIGRAINE (migraine). At the time of the report, PAIN IN EXTREMITY (pain in her arm/pain in her left arm) had resolved and BREAST PAIN (pain in her left breast), NECK PAIN (pain in her neck on the left), FEELING ABNORMAL (she did not feel good), ILLNESS (felt like she was getting sick), PAIN (pain under her left arm/pain in her left leg  ), MIGRAINE (migraine), CHILLS (had a chill), LYMPHADENOPATHY (swollen lymph nodes) and VACCINATION SITE RASH (injection site big red dot or rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment information was provided.  Patient had pain in her arm, which lasted for 3 days.   Most recent FOLLOW-UP information incorporated above includes: On 16-Sep-2021: Newevent Injection site big red dot or rash was added.
Painful arm from collar bone to wrist, fever (101), aches, headache, weak unable to get out of bed for 2 nights and days. Still feeling ill 5 days later.
Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Sore arm) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MYALGIA (Sore arm). At the time of the report, MYALGIA (Sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant product use was provided by the reporter.   No treatment medications were reported.   This case was linked to MOD-2021-313036, MOD-2021-313035 (Patient Link).
Within 7-8 hours had diffuse itching without rash.  Also over time developed mild itchy throat and lip swelling >24 hours after.  Has been using hydrocortisone cream and Benadryl.  Spoke with PCP 2 days after shot who advised her to continue those and advised against her getting the second shot.  She is feeling a little better030.  She is also documenting symptoms in website.